What does a White Blood Cell (WBC) count of 58 indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpretation of White Blood Cell Count of 58 × 10^9/L

A white blood cell (WBC) count of 58 × 10^9/L strongly suggests acute leukemia, most likely acute myeloid leukemia (AML) or acute promyelocytic leukemia (APL), and requires immediate hematology consultation and further diagnostic workup. 1

Clinical Significance of Extreme Leukocytosis

  • A WBC count of 58 × 10^9/L represents extreme leukocytosis, far exceeding the normal range (typically 4-11 × 10^9/L)
  • This level of leukocytosis falls into the category of hyperleukocytosis (>100 × 10^9/L) or approaching it, which is associated with:
    • Increased risk of mortality
    • Hemorrhagic events
    • Tumor lysis syndrome
    • Infections 1

Differential Diagnosis

Most Likely: Hematologic Malignancies

  • Acute leukemias:
    • Acute myeloid leukemia (AML)
    • Acute promyelocytic leukemia (APL)
    • Acute lymphoblastic leukemia (ALL)
  • Chronic leukemias in blast crisis:
    • Chronic myeloid leukemia (CML)
    • Chronic lymphocytic leukemia (CLL)

Less Likely: Severe Reactive Leukocytosis

  • Severe infection/sepsis
  • Inflammatory conditions
  • Tissue damage
  • Medication effect (e.g., corticosteroids)

Immediate Evaluation Required

  1. Complete blood count with differential to determine:

    • Types of white cells present (neutrophils, lymphocytes, blasts)
    • Presence of anemia or thrombocytopenia
    • Presence of left shift or immature forms 2, 3
  2. Peripheral blood smear examination - essential to:

    • Confirm the automated blood count
    • Identify blast cells
    • Assess for dysplasia
    • Distinguish between malignant and reactive processes 3
  3. Bone marrow examination if peripheral smear suggests malignancy

Urgent Management Considerations

For Suspected Leukemia

  • Immediate hematology/oncology consultation

  • Assess for hyperleukocytosis complications:

    • Respiratory symptoms (pulmonary infiltrates)
    • Neurological symptoms (cerebral hemorrhage)
    • Retinal hemorrhages 1
  • Cytoreductive therapy may be needed:

    • Hydroxyurea (2-4 g per day)
    • Consider leukapheresis for symptomatic hyperleukocytosis 1

For Suspected APL

  • Start ATRA immediately if APL is suspected based on clinical and laboratory features
  • Avoid invasive procedures (central venous catheterization, lumbar puncture) due to coagulopathy risk
  • Monitor for differentiation syndrome 1

For Suspected Severe Infection/Sepsis

  • Blood cultures (at least two sets from separate peripheral sites)
  • Empiric broad-spectrum antibiotics based on suspected source
  • Supportive care including fluid resuscitation if signs of sepsis 2

Pitfalls to Avoid

  1. Do not delay hematology consultation - extreme leukocytosis of this magnitude requires specialist input

  2. Do not miss hyperleukocytosis complications - these can be rapidly fatal:

    • Monitor for tumor lysis syndrome (hydration, allopurinol/rasburicase)
    • Avoid excessive red blood cell transfusions that can increase blood viscosity 1
  3. Do not assume infection - while severe infections can cause leukocytosis, a WBC count of 58 is more typical of hematologic malignancy

  4. Do not delay treatment for APL if suspected - start ATRA immediately while awaiting genetic confirmation 1

Follow-up Recommendations

  • Urgent flow cytometry and cytogenetic studies
  • Molecular studies for specific genetic abnormalities (e.g., PML-RARA for APL, FLT3 mutations)
  • Prepare for potential intensive chemotherapy or other targeted therapies based on diagnosis

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Sepsis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Malignant or benign leukocytosis.

Hematology. American Society of Hematology. Education Program, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.